Switch theme
Sign up to access all valuation multiples
Andon Health Co Ltd is a China-based company. It is principally engaged in the research and development, manufacture and distribution of medical instruments. Its main products include a blood pressure monitor, blood glucose monitor, TENS, electrical muscle stimulator, electronic pulse massager, and a digital thermometer.
1995
n/a
LTM Revenue $412M
LTM EBITDA $270M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Andon Health has a last 12-month revenue of $412M and a last 12-month EBITDA of $270M.
In the most recent fiscal year, Andon Health achieved revenue of $445M and an EBITDA of $234M.
Andon Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Andon Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $445M | $406M | XXX | XXX | XXX |
| Gross Profit | $210M | $2.9B | XXX | XXX | XXX |
| Gross Margin | 47% | 712% | XXX | XXX | XXX |
| EBITDA | $234M | $269M | XXX | XXX | XXX |
| EBITDA Margin | 53% | 66% | XXX | XXX | XXX |
| Net Profit | $125M | $2.2B | XXX | XXX | XXX |
| Net Margin | 28% | 545% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Andon Health's stock price is CNY 37 (or $5).
Andon Health has current market cap of CNY 17.4B (or $2.4B), and EV of CNY 10.0B (or $1.4B).
See Andon Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $2.4B | XXX | XXX | XXX | XXX | $0.43 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Andon Health has market cap of $2.4B and EV of $1.4B.
Andon Health's trades at 3.4x LTM EV/Revenue multiple, and 5.1x LTM EBITDA.
Analysts estimate Andon Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Andon Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.4B | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | XXX | XXX |
| EV/EBITDA | 5.1x | XXX | XXX | XXX |
| P/E | 11.5x | XXX | XXX | XXX |
| P/E/Growth | 1.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAndon Health's NTM/LTM revenue growth is 9%
Andon Health's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Andon Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Andon Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Andon Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -9% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 66% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 15% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 75% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 37% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Andon Health acquired XXX companies to date.
Last acquisition by Andon Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Andon Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Andon Health founded? | Andon Health was founded in 1995. |
| Where is Andon Health headquartered? | Andon Health is headquartered in China. |
| Is Andon Health publicy listed? | Yes, Andon Health is a public company listed on SHE. |
| What is the stock symbol of Andon Health? | Andon Health trades under 002432 ticker. |
| When did Andon Health go public? | Andon Health went public in 2010. |
| Who are competitors of Andon Health? | Similar companies to Andon Health include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Andon Health? | Andon Health's current market cap is $2.4B |
| What is the current revenue of Andon Health? | Andon Health's last 12-month revenue is $412M. |
| What is the current EBITDA of Andon Health? | Andon Health's last 12-month EBITDA is $270M. |
| What is the current EV/Revenue multiple of Andon Health? | Current revenue multiple of Andon Health is 3.4x. |
| What is the current EV/EBITDA multiple of Andon Health? | Current EBITDA multiple of Andon Health is 5.1x. |
| What is the current revenue growth of Andon Health? | Andon Health revenue growth between 2023 and 2024 was -9%. |
| Is Andon Health profitable? | Yes, Andon Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
